PubMed Sikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D.S., Brcic, L., Sever, M., Klicek, R., Radic, B., Drmic, D., Ilic, S., & Kolenc, D
1 Introduction Chimeric antigen receptor T (CAR-T) cell therapy is a pivotal innovation in the field of targeted immunotherapy, allowing for the direct recognition of tumor-associated antigens (TAAs) without requiring major histocompatibility complex (MHC)-mediated antigen presentation ( SLE is a severe autoimmune disorder, affecting primarily women of childbearing age with a prevalence of 0.1% in the general population ( With the advancement of innovative immunotherapies, CAR T-cell therapy holds great potential for treating patients with refractory SLE ( + B cells or BCMA + plasma cells or double-positive plasmablasts ( Taken together, this review aims to evaluate the potential of CAR-T cell therapy in treating SLE\-related diseases
Iron Bisglycinate Supplement 29 mg Highly absorbable Ferrochel iron designed to support healthy iron levels, red blood cell production, energy metabolism, and overall wellness. $17.08 Add to cart Advanced B Complex Supplement B-vitamin support for energy production and nervous system health
Thiol-Functionalized Cellulose-Grafted copper oxide nanoparticles for the therapy of experimental colitis in Swiss albino mice
